JP MORGAN/CALL/ELI LILLY & CO/1300/0.01/20.06.25 Stock

Warrant

DE000JK6Y0R4

Market Closed - Börse Stuttgart 09:56:33 2024-07-05 am EDT
0.27 EUR +3.85% Intraday chart for JP MORGAN/CALL/ELI LILLY & CO/1300/0.01/20.06.25

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 0.27 +3.85%
24-07-04 0.26 -7.14%
24-07-03 0.28 +3.70%
24-07-02 0.27 +3.85%
24-07-01 0.26 -3.70%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 09:56 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
Issuer J.P. Morgan
WKN JK6Y0R
ISINDE000JK6Y0R4
Date issued 2024-04-09
Strike 1,300 $
Maturity 2025-06-20 (348 Days)
Parity 100 : 1
Emission price 0.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.28
Lowest since issue 0.1
Spread 0.03
Spread %9.68%

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.6 USD
Average target price
870.3 USD
Spread / Average Target
-4.84%
Consensus